MyAverix Finance
US · Healthcare
Corix Bioscience Inc (CXBS)
Drug Manufacturers - Specialty & Generic
Corix Bioscience Inc (CXBS) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CXBS
Corix Bioscience Inc (CXBS) — FAQ
What is CXBS's P/E ratio?
The price-to-earnings (P/E) ratio for Corix Bioscience Inc (CXBS) is 18.00 (data as of 2026-03-24).
Does Corix Bioscience Inc pay a dividend?
Dividend yield is not available in the current snapshot for Corix Bioscience Inc (CXBS). Check the MyAverix Finance app for the latest dividend data.
What sector is Corix Bioscience Inc in?
Corix Bioscience Inc (CXBS) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is CXBS listed on?
CXBS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.